CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-K/A Report 10-K/A
- EFFECT Other Notice of Effectiveness
- 8-K Event Material agreement · Agreement ended
- 424B5 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- S-3/A Offering Registration Statement
- S-3 Offering Registration Statement
- 4 Grant or award CEO, President and Director acquired 73,600 shares (grant or award)
- 4 Grant or award See Remarks acquired 24,000 shares (grant or award)
Page 2 of 20 · 384 filings